Skip to main content

Trinity College Dublin, The University of Dublin

Menu Search


Trinity College Dublin By using this website you consent to the use of cookies in accordance with the Trinity cookie policy. For more information on cookies see our cookie policy.

      
Profile Photo

Professor Gerry Hanna

Professor / Consultant Radiation Oncolog (Radiation Therapy)
      
Profile Photo

Professor Gerry Hanna

Professor / Consultant Radiation Oncolog (Radiation Therapy)

 ghanna@tcd.ie

 


Professor Gerry Hanna is the Marie Curie Professor of Clinical Oncology at Trinity College Dublin and a Consultant in Radiation Oncology at the St Lukes Radiation Oncology Network and at the Trinity St James Cancer Institute. Gerry also holds honorary appointments at the Peter MacCallum Cancer Centre, Melbourne, the University of Melbourne and Queen"s University Belfast. Prof Hanna completed his undergraduate training at Queen"s University Belfast and his post graduate training at the Cancer Centre, Belfast City Hospital. Following his PhD fellowship, Prof Hanna was awarded the Royal College of Radiologists" Keith Durrant Memorial Travelling Fellowship to undertake a fellowship at the Vrije University Medical Centre in Amsterdam. Prior to taking up his current post, Prof Hanna was Chair of Division for Cancer and Specialist Medicine at Belfast Health and Social Care Trust and prior to this was the Director of Radiation Oncology at the Peter MacCallum Cancer Centre, Melbourne. His Research interests include the use of PET/CT in radiotherapy planning for lung cancer, mechanisms of radiotherapy resistance, stereotactic ablative radiotherapy and systemic therapy and immunotherapy combinations with radiotherapy. He was the chief investigator of the Peter Mac ACRF Radiation Immuno-oncology Program and the International Atomic Energy Agency's PERTAIN study. He is a TMG member for the UK's HALT, SARON, CONFIRM, ISOTOXIC IMRT and CONCORDE studies and continues to provide research support to Belfast Trust.
  Breast cancer   CANCER   CHEMO-RADIOTHERAPY   Lung Cancer   Non-small cell lung cancer   PET CT   Radiotherapy   Radiotherapy, Biological response modifiers and chemoprevention
Details Date From Date To
Founding Board Member of the Thoracic Oncology Group of Australasia. April 2019 Jully 2021
Supporting Ambassador of the European Society for Therapeutic Radiology and Oncology (ESTRO) January 2010
Fellow of the Royal Australian and New Zealand College of Radiologists June 2020 July 2024
Member of the Royal College of Physicians of London November 2021
Fellow of the Royal College of Radiologists, London May 2006
Honorary Fellow of the Faculty of Radiation Oncology and Radiology, Royal College of Surgeons of Ireland September 2023
Fellow Ulster Medical Society August 2010
Member of International Society for the Study of Lung Cancer (IASLC) June 2009
Member of British Thoracic Oncology Group (BTOG) April 2008
Vice-Clinical Lead of Cancer Trials Ireland November 2024
Member of the British Medical Association September 1993
Member of American Society for Therapeutic Radiology and Oncology (ASTRO) August 2010
Walls GM, McMahon M, Moore N, Nicol P, Bradley G, Whitten G, Young L, O'Hare JM, Lindsay J, Connolly R, Dermot Linden, Ball PA, Hanna GG, McAleese J, Clinicoradiological outcomes after radical radiotherapy for lung cancer in patients with interstitial lung disease., BJR open, 2023, Journal Article, PUBLISHED  TARA - Full Text  DOI
Walls, G.M., Giacometti, V., Apte, A., Thor, M., McCann, C., Hanna, G.G., O'Connor, J., Deasy, J.O., Hounsell, A.R., Butterworth, K.T., Cole, A.J., Jain, S., McGarry, C.K., Validation of an established deep learning auto-segmentation tool for cardiac substructures in 4D radiotherapy planning scans, Physics and Imaging in Radiation Oncology, 23, 2022, p118-126 , Journal Article, PUBLISHED  DOI
Gaudreault, M., Chang, D., Hardcastle, N., Jackson, P., Kron, T., Hanna, G.G., Hofman, M.S., Siva, S., Utility of Biology-Guided Radiotherapy to De Novo Metastases Diagnosed During Staging of High-Risk Biopsy-Proven Prostate Cancer, Frontiers in Oncology, 12, 2022, Journal Article, PUBLISHED  DOI
Salem, A., Franks, K., Greystoke, A., Hanna, G.G., Harrow, S., Hatton, M., Hiley, C., McDonald, F., Faivre-Finn, C., Unaccounted Confounders Limit the Ability to Draw Conclusions From Big Data Analysis Comparing Radiotherapy Fractionation Regimens in NSCLC, Journal of Thoracic Oncology, 17, (6), 2022, pe55-e56 , Journal Article, PUBLISHED  DOI
Diez, P., Hanna, G.G., Aitken, K.L., van As, N., Carver, A., Colaco, R.J., Conibear, J., Dunne, E.M., Eaton, D.J., Franks, K.N., Good, J.S., Harrow, S., Hatfield, P., Hawkins, M.A., Jain, S., McDonald, F., Patel, R., Rackley, T., Sanghera, P., Tree, A., Murray, L., UK 2022 Consensus on Normal Tissue Dose-Volume Constraints for Oligometastatic, Primary Lung and Hepatocellular Carcinoma Stereotactic Ablative Radiotherapy, Clinical Oncology, 34, (5), 2022, p288-300 , Journal Article, PUBLISHED  DOI
Gaudreault, M., Yeo, A., Kron, T., Hanna, G.G., Siva, S., Hardcastle, N., Treatment Time Optimization in Single Fraction Stereotactic Ablative Radiation Therapy: A 10-Year Institutional Experience, Advances in Radiation Oncology, 7, (5), 2022, Journal Article, PUBLISHED  DOI
Kothari, G., Woon, B., Patrick, C.J., Korte, J., Wee, L., Hanna, G.G., Kron, T., Hardcastle, N., Siva, S., The impact of inter-observer variation in delineation on robustness of radiomics features in non-small cell lung cancer, Scientific Reports, 12, (1), 2022, Journal Article, PUBLISHED  DOI
Walls, G.M., Osman, S.O.S., Brown, K.H., Butterworth, K.T., Hanna, G.G., Hounsell, A.R., McGarry, C.K., Leijenaar, R.T.H., Lambin, P., Cole, A.J., Jain, S., Radiomics for Predicting Lung Cancer Outcomes Following Radiotherapy: A Systematic Review, Clinical Oncology, 34, (3), 2022, pe107-e122 , Journal Article, PUBLISHED  DOI
Thippu Jayaprakash, K., Hanna, G.G., Hatton, M.Q., Lung Cancer in 2022 and Beyond!, Clinical Oncology, 34, (11), 2022, p695-697 , Journal Article, PUBLISHED  DOI
Siva, S., Jones, G., Bressel, M., Shaw, M., Chander, S., Chu, J., Plumridge, N., Byrne, K., Kothari, G., Hardcastle, N., Gaudreault, M., Kron, T., Wheeler, G., MacManus, M., Hanna, G.G., Ball, D.L., David, S., Impact of Medical Operability and Total Metastatic Ablation on Outcomes After SABR for Oligometastases, International Journal of Radiation Oncology Biology Physics, 114, (5), 2022, p862-870 , Journal Article, PUBLISHED  DOI
  

Page 1 of 11

  


Award Date
Winner of the St. Luke's Medal September 2007
Winner of Royal College of Radiologists, Keith Durrant Memorial Travelling Fellowship May 2009
Winner of Pearl Ewing Travelling Fellowship, Friends of the Cancer Centre, Belfast, N. Ireland. 2009
Winner of Best Post-Graduate Research, Faculty of Medicine, Annual Celebration of Excellence, Queen's University Belfast 2011
UK National Quality in Care Oncology Award 2016
Robert Campbell Oration Medal - Ulster Medical Society October 2011
Winner of the NI Healthcare Oncology Team Award April 2024
- Use of PET/CT in radiotherapy planning for lung cancer - Mechanisms of radiotherapy resistance - Stereotactic ablative radiotherapy (SABR/SBRT) - Systemic therapy and immunotherapy combinations with radiotherapy. - Chief investigator of International Atomic Energy Agency"s "PERTAIN" study. - Former chief investigator of the Peter Mac ACRF Radiation Immuno-oncology Program - Former chief investigator of the UK's CONCORDE Study. - TMG member for the UK"s HALT, SARON, CONFIRM, ISOTOXIC IMRT and CONCORDE studies